The stock market is usually considered the lifeblood of company funding. Since the first vaccination was released in November, the major financial markets in North America, Europe, and Asia have recovered, but the FTSE remains in negative territory. As a result, the central banks in some nations, including the UK, have decreased interest rates as a result. Lower borrowing costs and greater spending are expected to result in a positive impact on the economy. This is known as the "January effect," despite the fact that numerous money markets recovered ground in January. Vaccination program lockdowns and delays, according to analysts, might heighten market volatility in the coming year.

Only 39 of the 210 countries in the world have seen GDP growth of more than 1% in the past year. Countries that rely largely on tourism and hospitality, textiles, transportation and equipment manufacture, as well as energy and transportation, have been hit especially hard. It will be painful for countries like North America and Western Europe, who are largely dependent on domestic spending for growth. RMG exporter Bangladesh is likely to be affected by foreign supply shocks as well.

The response to the epidemic has already gotten the ball rolling on the first two stages of a long-term recovery. Some sort of "business as usual" may return if Stage 1 lockdown limitations are eased, while new enterprises, products, and services that both build on and disrupt business as usual are expected to spring up simultaneously. Globally, recovery will be unequal, and success at all three stages of pandemic recovery will depend on how other nations are responding. Global commerce, investment, and supply networks make it difficult for some countries to recover from the epidemic, while a new wave may also impede recovery efforts.